FCGR2B and rheumatoid arthritis: A reduction in FcγRIIB expression level has been observed in memory B cell populations in patients with SLE [365] and RA [366] which could be indicative of a loss of FcγRIIB-mediated checkpoint inhibition and enabling the expansion of autoreactive B cells.